ENVERIC BIOSCIENCES INC (ENVB) Stock Overview
USA - NASDAQ:ENVB - US29405E4061 - Common Stock
ENVB Key Statistics, Chart & Performance
The current stock price of ENVB is 0.7591 USD. In the past month the price increased by 26.18%. In the past year, price decreased by -88.68%.
ENVB Latest News, Press Relases and Analysis
ENVB Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 49.71 | 759.85B | ||
| JNJ | JOHNSON & JOHNSON | 18.61 | 465.34B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 19.07 | 262.58B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.85 | 254.43B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 13.94 | 241.59B | ||
| MRK | MERCK & CO. INC. | 11.01 | 211.79B | ||
| PFE | PFIZER INC | 7.23 | 139.35B | ||
| SNY | SANOFI-ADR | 11.4 | 123.36B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.48 | 88.81B | ||
| GSK | GSK PLC-SPON ADR | 9.74 | 88.32B | ||
| ZTS | ZOETIS INC | 23.16 | 63.84B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 48.41 | 44.34B |
Related stock screener links
About ENVB
Company Profile
Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company is headquartered in Cambridge, Massachusetts and currently employs 5 full-time employees. The company went IPO on 2009-07-21. The firm is engaged in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. Leveraging its discovery and development platform, the Psybrary platform, which houses proprietary information on the use and development of existing and novel molecules for specific mental health indications, the Company seeks to develop a robust intellectual property portfolio of drug candidates. Its lead molecule, EB-003, is a neuroplastogen designed to promote neuroplasticity, without inducing hallucinations, in patients suffering from difficult-to-address mental health disorders. The firm is focused on advancing EB-003 towards clinical trials for the treatment of neuropsychiatric disorders while out-licensing other Psybrary platform drug candidates to third-party licensees and advancing non-competitive market strategies for patient care.
Company Info
ENVERIC BIOSCIENCES INC
245 First Street Riverview Ii 18Th Floor
Cambridge MASSACHUSETTS 34103 US
CEO: David Johnson
Employees: 6
Phone: 12393021707
ENVERIC BIOSCIENCES INC / ENVB FAQ
What is the stock price of ENVERIC BIOSCIENCES INC today?
The current stock price of ENVB is 0.7591 USD. The price decreased by -3.68% in the last trading session.
What is the ticker symbol for ENVERIC BIOSCIENCES INC stock?
The exchange symbol of ENVERIC BIOSCIENCES INC is ENVB and it is listed on the Nasdaq exchange.
On which exchange is ENVB stock listed?
ENVB stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ENVERIC BIOSCIENCES INC stock?
7 analysts have analysed ENVB and the average price target is 10.2 USD. This implies a price increase of 1243.7% is expected in the next year compared to the current price of 0.7591. Check the ENVERIC BIOSCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ENVERIC BIOSCIENCES INC worth?
ENVERIC BIOSCIENCES INC (ENVB) has a market capitalization of 2.47M USD. This makes ENVB a Nano Cap stock.
How many employees does ENVERIC BIOSCIENCES INC have?
ENVERIC BIOSCIENCES INC (ENVB) currently has 6 employees.
What are the support and resistance levels for ENVERIC BIOSCIENCES INC (ENVB) stock?
ENVERIC BIOSCIENCES INC (ENVB) has a support level at 0.64 and a resistance level at 1.06. Check the full technical report for a detailed analysis of ENVB support and resistance levels.
Should I buy ENVERIC BIOSCIENCES INC (ENVB) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ENVB, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ENVB, evaluating the profitability, health, valuation and growth aspects
- ENVERIC BIOSCIENCES INC (ENVB) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ENVERIC BIOSCIENCES INC (ENVB) Sales and EPS estimates to see what analysts future expectations are.
- ENVERIC BIOSCIENCES INC (ENVB) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ENVERIC BIOSCIENCES INC (ENVB) Insider and Institutional Ownership to learn about the owners and their transactions.
- ENVERIC BIOSCIENCES INC (ENVB) Stock Chart to make your own analysis
- ENVERIC BIOSCIENCES INC (ENVB) Latest news and press-releases to stay up to date.
Does ENVERIC BIOSCIENCES INC (ENVB) stock pay dividends?
ENVB does not pay a dividend.
When does ENVERIC BIOSCIENCES INC (ENVB) report earnings?
ENVERIC BIOSCIENCES INC (ENVB) will report earnings on 2025-11-12, before the market open.
What is the Price/Earnings (PE) ratio of ENVERIC BIOSCIENCES INC (ENVB)?
ENVERIC BIOSCIENCES INC (ENVB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-21.3).
What is the Short Interest ratio of ENVERIC BIOSCIENCES INC (ENVB) stock?
The outstanding short interest for ENVERIC BIOSCIENCES INC (ENVB) is 12.51% of its float. Check the ownership tab for more information on the ENVB short interest.
ENVB Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ENVB. When comparing the yearly performance of all stocks, ENVB is a bad performer in the overall market: 98.63% of all stocks are doing better.
ENVB Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ENVB. While ENVB seems to be doing ok healthwise, there are quite some concerns on its profitability.
ENVB Financial Highlights
Over the last trailing twelve months ENVB reported a non-GAAP Earnings per Share(EPS) of -21.3. The EPS increased by 80.77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -280.2% | ||
| ROE | -455.09% | ||
| Debt/Equity | 0 |
ENVB Forecast & Estimates
7 analysts have analysed ENVB and the average price target is 10.2 USD. This implies a price increase of 1243.7% is expected in the next year compared to the current price of 0.7591.